A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants
NCT06058390
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
160
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B
Interventions
DRUG:
Bepirovirsen
Sponsor
GlaxoSmithKline